Related Experiment Video
Updated: Mar 26, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Provider communication about HPV vaccination: A systematic review
Melissa B Gilkey1, Annie-Laurie McRee2
1a Department of Population Medicine , Harvard Medical School & Harvard Pilgrim Health Care Institute , Boston , MA.
Healthcare providers need better strategies for recommending the human papillomavirus (HPV) vaccine. Studies show provider discomfort and mixed messages hinder effective HPV vaccination communication, impacting coverage rates.
Area of Science:
- Public Health
- Health Communication
- Vaccinology
Background:
- Improving human papillomavirus (HPV) vaccination coverage in the U.S. is crucial.
- Effective healthcare provider recommendations are key to increasing vaccination rates.
Purpose of the Study:
- To systematically review studies on provider communication strategies for HPV vaccination.
- To inform quality improvement initiatives aimed at enhancing HPV vaccine uptake.
Main Methods:
- Conducted a systematic literature search across major databases (MEDLINE, CINAHL, EMBASE, POPLINE) in August 2015.
- Included 101 qualitative and quantitative studies examining provider-patient communication regarding HPV vaccination.
Main Results:
- Provider discomfort discussing sensitive topics and perceived parental hesitancy were barriers to recommendation.
- Younger patients, males, and racial/ethnic minorities were less likely to receive recommendations.
- Providers often delivered mixed messages, failing to strongly endorse the HPV vaccine or presenting it as optional.
Conclusions:
- Targeted interventions are necessary to equip healthcare providers with effective communication skills for HPV vaccination.
- Addressing provider-based barriers and improving recommendation clarity can enhance vaccine acceptance.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Vaccines
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...